Genmab | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
Agios Pharmaceuticals USD -89289000 16.11M 2025-03
Almirall EUR 35.8M 37.9M 2025-03
Amarin USD -13630000 197K 2025-03
Amgen USD 3.38B 111M 2024-12
argenx SE USD 202.36M 114.34M 2025-03
AstraZeneca USD 3.4B 1.74B 2025-03
Bayer EUR 1.83B 2.31B 2025-03
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Demant DKK 967M 76M 2024-12
Exelixis USD 205.69M 20.92M 2025-03
Fresenius Medical Care EUR 179.93M 201.07M 2024-12
Galapagos EUR -156367000 175.4M 2025-03
Genmab DKK 244M 3.36B 2025-03
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
GN Store Nord DKK 114M 93M 2025-03
GRIFOLS EUR 210.54M 143.56M 2024-12
Hikma Pharmaceutical USD 144M 144M 2024-06
Insmed USD -255671000 21.39M 2025-03
Lonza CHF 624M 197M 2024-12
Merck EUR 956M 147M 2025-03
Novartis USD 4.53B 124M 2025-06
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.16B 20M 2025-03
UCB EUR 1.22B 781M 2024-12


Genmab L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.